Hikari Power’s Acadia Pharmaceuticals ACAD Stock Holding History

Hikari Power’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,535	Closed	-$495K	–	117
2019 Q2	$495K	Sell	18,535 -1,465	-7%	-$37.4K	0.05%	73
2019 Q1	$537K	Hold	20,000	–	–	0.06%	69
2018 Q4	$323K	Buy	+20,000	New	+$388K	0.04%	80
2018 Q3	–	Sell	-60,000	Closed	-$916K	–	128
2018 Q2	$916K	Buy	60,000 +20,000	+50%	+$357K	0.1%	67
2018 Q1	$899K	Hold	40,000	–	–	0.11%	64
2017 Q4	$1.2M	Hold	40,000	–	–	0.14%	56
2017 Q3	$1.51M	Sell	40,000 -20,000	-33%	-$651K	0.19%	49
2017 Q2	$1.67M	Hold	60,000	–	–	0.23%	44
2017 Q1	$2.06M	Hold	60,000	–	–	0.29%	37
2016 Q4	$1.73M	Buy	+60,000	New	+$1.59M	0.25%	40

Other funds holding ACAD

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return